Eli Lilly

Pharma Courses

  • A new medication to be launched by the end of this year by US Pharma major Eli Lilly, for diabetic patients in India. A regulatory approval for the upcoming product has already been received by the company. It is also gearing up to introduce another medication in oncology that could be launched by the end of 2016 or early 2017 which has been filed for approvals.

  • 24 June 2015
    Lilly, Dana-Farber Cancer Institute collaborate to develop new medicines to treat cancer

    Eli Lilly and Company and Dana-Farber Cancer Institute, a principal teaching affiliate of Harvard Medical School,  collaborate  to research new medicines under development  to fight cancer.

  • US Food and Drug Administration (FDA) has approved Eli Lilly and Company Humalog 200 units/mL KwikPen (insulin lispro 200 units/mL; U-200), a pre-filled pen containing a concentrated formulation of Lilly's rapid-acting insulin Humalog (insulin lispro 100 units/mL) Humalog U-200 KwikPen is used to improve glycemic control in people with type 1 and type 2 diabetes.

  • 16 December 2014
    Career for Sales representative-Diabetes at Lilly | Bangalore

    Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.  We were founded in 1876 by Colonel Eli Lilly, a man committed to creating high-quality medicines that meet real needs.

  • 5 December 2014
    Vacancy as TM-Diabetes in Lilly

    Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.  We were founded in 1876 by Colonel Eli Lilly, a man committed to creating high-quality medicines that meet real needs.

  • 3 September 2011
    Eli Lilly India (Lilly) and Lupin Limited (Lupin) Announced Strategic Collaboration to Help Fight the Battle Against Diabetes

    Eli Lilly India (Lilly) and Lupin Limited (Lupin) announced on 29th July, 2011 that they have entered into a strategic collaboration to promote and distribute Lilly’s Huminsulin range of products, including Huminsulin RTM, Huminsulin NPHTM, Huminsulin 50/50TM, Huminsulin 30/70TM and Humapen Ergo II. Lupin’s India formulations business will promote and distribute the range of products in India and Nepal, virtually doubling the number of sales representatives behind the diabetes care product.

  • 12 June 2011
    2011 Eli Lilly and Company Asia Outstanding Thesis Awards

    National Organic Symposium Trust (NOST) invites nominations for 2011 Eli Lilly and Company Asia Outstanding Thesis Awards from Ph.D. scientists who have submitted their thesis and made significant contributions in the field of medicinal chemistry, organic synthesis, computational chemistry, structural biology or analytical chemistry.

  • 19 November 2010
    Opportunity for Indian Candidates to fly US with Lilly | Freshers can also apply.

    Lilly USA, LLC has been dedicated to meeting the health care needs of people in the United States and around the world. We address these needs primarily by developing innovative medicines—investing a higher percentage of our sales in research and development than any other major pharmaceutical company. If you are interested in being considered for employment with a “Best in Class” Pharmaceutical company, please review the following opportunity:

  • 26 April 2010
    Liraglutide Superior to Sitagliptin When Added to Metformin for Glycemic Control

    The addition of a glucagonlike peptide-1 (GLP-1) agonist in patients with inadequate glycemic control when treated with metformin alone resulted in significantly larger reductions in HbA1c levels when compared with the addition of a dipeptidyl peptidase-4 (DPP-4) inhibitor, a new study has shown.

Subscribe to Eli Lilly